Schick Shadel Hospital is helping people with addiction to alcohol and drugs curb their craving. Now, the Schick Shadel Foundation is making it possible for individuals, groups and corporations to be a part of the effort.

The Schick Shadel Foundation is pursing the cure for addiction through:

·          Research – furthering research in aversion therapy and its application to chemical dependency.

·          Education – providing programs and educational material to support individuals, families and the community it serves.

·          Scholarships – providing funding to support those in need of treatment.

 

Addiction to various types of drugs or alcohol plays no favorites - it crosses all cultural and economic boundaries. One in 11 persons who ever try alcohol or illicit drugs will become addicted. Once alcoholism and drug dependency take root, they are brain diseases. And each afflicted person affects the lives of everyone with whom they interact: family, friends and associates.

 

As a complement to the hospital, the foundation is dedicated to making the aversion process even more successful for even more patients. Through research the foundation hopes to verify its success, improve its success rate, and systematize the protocol for use with chemical dependencies.  In addition. , the foundation will participate in the effort, through education,  to prevent, to intervene and to treat chemical dependency, and finally it will , upon board approval, may provide treatment for addicts who want help and are under-funded or have limited insurance benefits.

 

The Schick Shadel Foundation's ability to help depends on the support the foundation receives. A 501 (c)(3) non-profit organization in the State of Washington, all contributions are tax deductible.

 

For more information contact: Amy Maki at 206-244-8100 or at amym@SchickShadel.com


 
 

Mission

 Board of Directors
  Donate How You Can Help




 



  Schick Shadel Hospital's unique medical treatment using aversion therapy maintains the #1 success rate in treating alcoholism, and 70 percent of its patients retain a life-long aversion to alcohol or drugs.